Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(18)
•••
Comment by patels96on Apr 27, 2018 11:26am
88 Views
Post# 27950257

RE:RE:RE:RE:release date of financials ??

RE:RE:RE:RE:release date of financials ??We all know they will have negative eanrings, but the question is why couldnt they commnuicate that earnings will be released at this date...the communication and transparency from this company is lacking. Furthermore, I'm more interested in the MD&A and outlook section

Also, their presentation needs work, if you look at Aphria or Medreleaf they have a more detailed presentation which covers their cash costs, revenue growth, volumes producded, and they identify their competitive advantages to competitors all of which provides insight for an investor

This company has a lot of potential, but Graham Farrell is doing a very poor job of communicating and providing the necessary transparency for Maricann

Best,
Maricann Shareholder
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities